{"id":"d9e102c59043","type":"article","url":"https://hartvaat.nl/2019/09/24/asymptomatische-patienten-met-abnormale-ffr-medicamenteus-versus-pci/","title":"Asymptomatische patiënten met abnormale FFR: medicamenteus versus PCI","title_en":"Asymptomatic Patients With Abnormal Fractional Flow Reserve Treated With Medication Alone or With PCI.","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":[],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2019.07.068","source_url":"https://doi.org/10.1016/j.jacc.2019.07.068","authors":["Stephane Fournier","Yuhei Kobayashi","William F Fearon","Carlos Collet","Bruno Roza da Costa","Gilles Rioufol","Nico H J Pijls","Peter Jüni","Bernard De Bruyne"],"significance":6,"published":"2019-09-24","source_date":"2019-09-24","image":"","kennis":[],"congress":"","summary_en":"This study evaluated outcomes of asymptomatic patients with hemodynamically significant lesions (abnormal FFR) managed with medication alone versus PCI, addressing the clinical dilemma of treating physiologically significant but symptom-free disease.","created":"2026-07-03T10:28:09Z","updated":"2026-07-03T13:27:21Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Studie naar de uitkomsten van asymptomatische patiënten met abnormale FFR-waarden behandeld met medicatie alleen versus PCI.","abstract_original":""}